Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01702077 · ClinicalTrials.gov registry record · NA

Neurofeedback for Tourette Syndrome

A NA study of Tourette Syndrome and Chronic Tic Disorder, sponsored by Yale University.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT01702077 is a NA study of Tourette Syndrome and Chronic Tic Disorder that has completed, run by Yale University. The registered enrollment target is 21 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01702077, a NA study of Tourette Syndrome and Chronic Tic Disorder, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to train patients with tic disorders to control activity in a region of their brain that has been associated with the urge to tic. Patients will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control activity in the region during these feedback sessions. In separate sessions, patients will be given sham feedback based on the brain patterns of a prior subject rather than their own brain patterns. Our primary hypothesis is that the biofeedback training will reduce their tic symptoms more than the sham feedback.

Interventions

  • PROCEDURE Neurofeedback
  • PROCEDURE Sham feedback

Study Locations (1)

Connecticut

  • Yale University School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2012-10
Est. Completion 2017-12
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT01702077

The ClinicalTrials.gov registry entry for NCT01702077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (76% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Neurofeedback is the first listed.

NCT01702077 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01702077 about?

NCT01702077 is a clinical study titled "Neurofeedback for Tourette Syndrome". The aim of this study is to train patients with tic disorders to control activity in a region of their brain that has been associated with the urge to tic. Patients will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fM...

What is the current status of trial NCT01702077?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2012-10. Estimated completion is 2017-12.

What conditions does trial NCT01702077 study?

This clinical trial studies the following conditions: Tourette Syndrome, Chronic Tic Disorder.

What interventions are being tested in trial NCT01702077?

The interventions under investigation include: Neurofeedback (PROCEDURE), Sham feedback (PROCEDURE).

Who is sponsoring clinical trial NCT01702077?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01702077 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.